CytoMed Therapeutics Ltd
NASDAQ:GDTC 3:59:40 PM EDT
Market Cap (Intraday) | 37.30M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.57 |
50-Day MA | $3.80 |
200-Day MA | N/A |
CytoMed Therapeutics Ltd Stock, NASDAQ:GDTC
1 Commonwealth Lane, No. 08-22, One Commonwealth, Singapore, Central Singapore 149544
Singapore
Phone: +65.6250.7738
Number of Employees: 28
Description
CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.